Document is current

Article History

Received: 18 July 2018

Accepted: 11 December 2018

First Online: 27 December 2018

Ethics approval and consent to participate

: The project received ethics approval from the University of Waterloo Office of Research Ethics (ORE no 17045). The need for consent is deemed unnecessary because the MDS 2.0 assessments are performed in Long-term care homes on all residents as part of regular clinical practice that is mandated by the Ministries of Health in the relevant Canadian provinces. For example, in Ontario, the Health Care Consent Act provides rules with respect to consent to treatment in a Health Care environment. It specifically states that the “assessment or examination of a person to determine the general nature of the person’s condition is not considered to be treatment and would therefore not require consent”.

: Not applicable.

: All authors declare no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; no other relationships or activities that could appear to have influenced the submitted work (GI, MJ, JB, JPH, LT, JR). JPH reported funding from PHAC. AN reported funding from Osteoporosis Canada. LG reports personal fees from ICON. AP and LP report grants from Ontario Ministry of Health and Long-Term Care Ontario Osteoporosis Strategy. JDA reports grants and personal fees from Amgen, grants and personal fees from Eli Lilly, personal fees from AgNovos, during the conduct of the study; non-financial support from Osteoporosis Canada, non-financial support from International Osteoporosis Foundation, outside the submitted work.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.